Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kathleen Zelin"'
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d17693143f6c29196ed44e6530bc8964
https://doi.org/10.2139/ssrn.3795908
https://doi.org/10.2139/ssrn.3795908
Publikováno v:
JACC: Clinical Electrophysiology. 3:830-841
Objectives The purpose of this study was to use direct cardiac resynchronization therapy (CRT)-paced contractility (dP/dt-max) response as a pre-implantation evaluation among patients with congenital heart disease (CHD) and follow clinical parameters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b270dce71da9f6a784eaadb8e7fef7be
https://doi.org/10.1016/j.jacep.2017.01.015
https://doi.org/10.1016/j.jacep.2017.01.015
Publikováno v:
Pacing and Clinical Electrophysiology. 40:17-25
BACKGROUND Patients with congenital heart defects (CHD) often present more challenges to pacing therapy due to anatomy than those without CHD. The lumenless, 4.1Fr diameter M3830 pacing lead (Medtronic, Inc., Minneapolis, MN, USA), approved for use i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54abff1b33f2fbc16bc8095c8cea1d8e
https://doi.org/10.1111/pace.12995
https://doi.org/10.1111/pace.12995
Publikováno v:
Pacing and Clinical Electrophysiology. 38:1343-1350
Background Standard, 5–7-Fr diameter pacing leads (PLs) can adversely affect atrioventricular valve (AVV) and venous (superior vena cava [SVC], innominate [INN]) integrities. Although chronic pacing/sensing performances have been reported on the st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98a3b4d6a5f06f50cd671f1bea04c6f7
https://doi.org/10.1111/pace.12728
https://doi.org/10.1111/pace.12728
Publikováno v:
JACC. Clinical electrophysiology. 3(8)
The purpose of this study was to use direct cardiac resynchronization therapy (CRT)-paced contractility (dP/dt-max) response as a pre-implantation evaluation among patients with congenital heart disease (CHD) and follow clinical parameters and contra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::76a7fe45e03ebaebb1e31d42fe69342d
https://pubmed.ncbi.nlm.nih.gov/29759780
https://pubmed.ncbi.nlm.nih.gov/29759780
Publikováno v:
Pacing and clinical electrophysiology : PACE. 40(1)
Patients with congenital heart defects (CHD) often present more challenges to pacing therapy due to anatomy than those without CHD. The lumenless, 4.1Fr diameter M3830 pacing lead (Medtronic, Inc., Minneapolis, MN, USA), approved for use in 2005, has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1d30aa8e0b38643a0888058eda2b385a
https://pubmed.ncbi.nlm.nih.gov/28004408
https://pubmed.ncbi.nlm.nih.gov/28004408
Publikováno v:
Pacing and Clinical Electrophysiology. 33:1467-1474
Purpose: United States approval of the Model 3830, 4.1-French (Fr) diameter, lumenless, pacing lead (Medtronic Inc., Minneapolis, MN, USA) in patients under 17 years of age, and those with congenital heart disease (CHD), was in 2005. To date, long-te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7902ac4c6964be63e8d19066a8645c7
https://doi.org/10.1111/j.1540-8159.2010.02884.x
https://doi.org/10.1111/j.1540-8159.2010.02884.x
Publikováno v:
Pacing and clinical electrophysiology : PACE. 38(11)
Standard, 5-7-Fr diameter pacing leads (PLs) can adversely affect atrioventricular valve (AVV) and venous (superior vena cava [SVC], innominate [INN]) integrities. Although chronic pacing/sensing performances have been reported on the steroid-eluting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::94a09331ed19855c8ed6195225d14f28
https://pubmed.ncbi.nlm.nih.gov/26256093
https://pubmed.ncbi.nlm.nih.gov/26256093
Publikováno v:
Pacing and clinical electrophysiology : PACE. 38(1)
This study evaluates the concept of optimizing ventricular pacing in regard to functional cardiac response. Lead implant based on physiologic variables of contractility at various sites was performed in patients with and without congenital heart dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb7969f8335400739d0ee09dfcdca2ba
https://pubmed.ncbi.nlm.nih.gov/25311823
https://pubmed.ncbi.nlm.nih.gov/25311823
Publikováno v:
Pacing and clinical electrophysiology : PACE. 33(12)
United States approval of the Model 3830, 4.1-French (Fr) diameter, lumenless, pacing lead (Medtronic Inc., Minneapolis, MN, USA) in patients under 17 years of age, and those with congenital heart disease (CHD), was in 2005. To date, long-term perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::745272104b1bfbc30999ceea577cc38e
https://pubmed.ncbi.nlm.nih.gov/20723078
https://pubmed.ncbi.nlm.nih.gov/20723078